Induction of myelinating oligodendrocytes in human cortical spheroids M Madhavan, ZS Nevin, HE Shick, E Garrison, C Clarkson-Paredes, ... Nature methods 15 (9), 700-706, 2018 | 290 | 2018 |
IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination AD Pusic, KM Pusic, BLL Clayton, RP Kraig Journal of neuroimmunology 266 (1-2), 12-23, 2014 | 214 | 2014 |
Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts P De Rossi, V Buggia-Prévot, BLL Clayton, JB Vasquez, C Van Sanford, ... Molecular neurodegeneration 11, 1-21, 2016 | 131 | 2016 |
Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis W Lin, Y Lin, J Li, AG Fenstermaker, SW Way, B Clayton, S Jamison, ... Journal of Neuroscience 33 (14), 5980-5991, 2013 | 128 | 2013 |
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic SW Way, JR Podojil, BL Clayton, A Zaremba, TL Collins, RB Kunjamma, ... Nature communications 6 (1), 6532, 2015 | 120 | 2015 |
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia BLL Clayton, B Popko Brain research 1648, 594-602, 2016 | 96 | 2016 |
Non-canonical targets of HIF1a impair oligodendrocyte progenitor cell function KC Allan, LR Hu, MA Scavuzzo, AR Morton, AS Gevorgyan, EF Cohn, ... Cell stem cell 28 (2), 257-272. e11, 2021 | 41 | 2021 |
Chemical screening identifies enhancers of mutant oligodendrocyte survival and unmasks a distinct pathological phase in Pelizaeus-Merzbacher disease MS Elitt, HE Shick, M Madhavan, KC Allan, BLL Clayton, C Weng, ... Stem Cell Reports 11 (3), 711-726, 2018 | 40 | 2018 |
Oligodendrocyte progenitor cell fate and function in development and disease BLL Clayton, PJ Tesar Current opinion in cell biology 73, 35-40, 2021 | 37 | 2021 |
Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells AM Lager, OG Corradin, JM Cregg, MS Elitt, HE Shick, BLL Clayton, ... Nature Communications 9 (1), 3708, 2018 | 23 | 2018 |
Developing therapeutic strategies to promote myelin repair in multiple sclerosis LE Baldassari, J Feng, BLL Clayton, SH Oh, K Sakaie, PJ Tesar, Y Wang, ... Expert Review of Neurotherapeutics 19 (10), 997-1013, 2019 | 22 | 2019 |
Pervasive environmental chemicals impair oligodendrocyte development EF Cohn, BLL Clayton, M Madhavan, KA Lee, S Yacoub, Y Fedorov, ... Nature Neuroscience 27 (5), 836-845, 2024 | 12 | 2024 |
The integrated stress response in hypoxia-induced diffuse white matter injury BL Clayton, A Huang, RB Kunjamma, A Solanki, B Popko Journal of Neuroscience 37 (31), 7465-7480, 2017 | 11 | 2017 |
A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity BLL Clayton, JD Kristell, KC Allan, EF Cohn, M Karl, AD Jerome, ... Nature neuroscience 27 (4), 656-665, 2024 | 10 | 2024 |
Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis BLL Clayton, L Barbar, M Sapar, K Kalpana, C Rao, B Migliori, ... Cell Stem Cell 31 (11), 1701-1713. e8, 2024 | 7 | 2024 |
Neonatal hypoxia results in peripheral nerve abnormalities BLL Clayton, A Huang, D Dukala, B Soliven, B Popko The American journal of pathology 187 (2), 245-251, 2017 | 5 | 2017 |
Non-canonical targets of HIF1a drive cell-type-specific dysfunction KC Allan, LR Hu, AR Morton, MA Scavuzzo, AS Gevorgyan, BLL Clayton, ... BioRxiv, 2020.04. 03.003632, 2020 | 3 | 2020 |
Disorders of myelin BLL Clayton, KC Allan, ZS Nevin, MS Elitt, PJ Tesar Neurodevelopmental Disorders, 309-335, 2020 | 2 | 2020 |
Cellular Maturation of Oligodendrocytes is Governed by Transient Gene Melting KC Allan, TE Miller, AR Morton, MA Scavuzzo, MS Elitt, BLL Clayton, ... bioRxiv, 2022.11. 17.516981, 2022 | 1 | 2022 |
Chemical inhibition of pathological reactive astrocytes promotes neural protection BLL Clayton, JD Kristell, KC Allan, M Karl, E Garrison, Y Maeno-Hikichi, ... bioRxiv, 2021.11. 03.467083, 2021 | 1 | 2021 |